Advertisement

The Editor's Roundtable: Effect of Nonsteroidal Anti-Inflammatory Drugs on Blood Pressure

  • Vincent E. Friedewald
    Correspondence
    Corresponding author: Tel: 512-264-1611; fax: 512-264-8939
    Affiliations
    Associate Editor, The American Journal of Cardiology, Clinical Professor, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, and Research Professor, College of Science, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • C. Venkata S. Ram
    Affiliations
    Clinical Professor of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas
    Search for articles by this author
  • Donald E. Wesson
    Affiliations
    Vice Dean, Texas A&M College of Medicine, Temple, Texas, and Chief Academic Officer, Scott and White Healthcare, Temple, Texas
    Search for articles by this author
  • William B. White
    Affiliations
    Professor and Chief, Division of Hypertension & Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut, and Editor-in-Chief, Blood Pressure Monitoring
    Search for articles by this author
  • Gary W. Williams
    Affiliations
    Chairman, Department of Medicine, Immediate Past Chief, Division of Rheumatology, Scripps Clinical Medical Group, La Jolla, California and Vice President, Medicine Services, Scripps Clinic Foundation, La Jolla, California
    Search for articles by this author
  • William C. Roberts
    Affiliations
    Editor-in-Chief, The American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
    Search for articles by this author
      This CME activity is supported by an educational grant from NicOx, Warren, New Jersey.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Johnson A.G.
        • Nguyen T.V.
        • Day R.O.
        Do nonsteroidal anti-inflammatory drugs affect blood pressure?.
        Ann Intern Med. 1994; 121: 289-300
        • Chobanian A.V.
        • Bakris G.L.
        • Black H.R.
        • Cushman W.C.
        • Green L.A.
        • Izzo Jr, J.L.
        • Jones D.W.
        • Materson B.J.
        • Oparil S.
        • Wright Jr, J.T.
        • Roccella E.J.
        • Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee
        Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
        Hypertension. 2003; 42: 1206-1252
        • Calhoun D.A.
        • Jones D.
        • Textor S.
        • Goff D.C.
        • Murphy T.P.
        • Toto R.D.
        • White A.
        • Cushman W.C.
        • White W.
        • Sica D.
        • Ferdinand K.
        • Giles T.D.
        • Falkner B.
        • Carey R.M.
        Resistant hypertension: diagnosis, evaluation, and treatment.
        Circulation. 2008; 117: e510-e526
        • Whelton A.
        • Schulman G.
        • Wallemark C.
        • Drower E.J.
        • Isakson P.C.
        • Verburg K.M.
        • Geis G.S.
        Effects of celecoxib and naproxen on renal function in the elderly.
        Arch Intern Med. 2000; 160: 1465-1470
        • Feenstra J.
        • Heerdink E.R.
        • Grobbee D.E.
        • Stricker B.H.C.
        Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam study.
        Arch Intern Med. 2002; 162: 265-270
        • Sowers J.R.
        • White W.B.
        • Pitt B.
        • Whelton A.
        • Simon L.S.
        • Winer N.
        • Kivitz A.
        • van Ingen H.
        • Brabant T.
        • Fort J.G.
        • Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators
        The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
        Arch Intern Med. 2005; 165: 161-168
        • Whelton A.
        • White W.B.
        • Bello A.E.
        • Puma J.A.
        • Fort J.G.
        • SUCCESS-VII Investigators
        Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritis.
        Am J Cardiol. 2002; 90: 959-963

      Linked Article